Why is the government shutdown lasting so long?
What caused Apple stock to decline today?
How will Kimberly-Clark's Kenvue acquisition impact the market?
Why did Amazon sign $38B deal with OpenAI?
What does the Nvidia chip export ban to China mean?
How did OPEC+ production pause affect oil prices?
Why are crypto assets plunging this week?
uniQure (NASDAQ: QURE) updates on AMT-130; FDA feedback shifts, BLA timing unclear
stocktitan.net/news/QURE/uni-qure-provides-regulatory-update-on-amt-130-for-huntington-s-go0k2ksf4qls.html
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
uniQure (NASDAQ: QURE) on Nov. 3, 2025 announced FDA feedback from a pre-BLA meeting for AMT-130, its investigational gene therapy for Huntington’s disease.
uniQure said the FDA now appears to disagree that Phase I/II…
This story appeared on stocktitan.net, 2025-11-03 12:59:34.656000.